Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/12/960   
Active ingredient: Glucagon
Indication: Treatment of congenital hyperinsulinism
Sponsor: Biodel UK Limited
41 Chalton Street, London NW1 1JD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/03/2012 Orphan designation EMA/OD/140/11 (2012)1530 of 05/03/2012